We are an international team of senior consultants and operation management.
The EII management team is composed of professionals who have long been engaged in the healthcare industries in China and overseas. With extensive management experience, broad international vision and rich industry and government resources, these professionals have participated in the M&A and management of more than 30 large and medium-sized hospitals in different regions and companies in the past few years. Their outstanding performance showcases EII’s excellent management and operation capabilities in the diabetes industry.
The University of Edinburgh has appointed Dr Tao David JIANG as the Chairman, Professor Jonathan Seckl, the Vice Principal of Planning, Resources and Research Policy at the University of Edinburgh, as the Vice Chairman, Mr Phil McNaull, the former Director of Finance at the University of Edinburgh, Mr Gang ZHENG, and Professor Chenli LIU, the Director of CAS Key Laboratory for Quantitative Engineering Biology, the Head of the Department of Synthetic Biology at the Shenzhen Institute of Advanced Technology, and the Chief Scientist of the National Key Research and Development Program enjoying the special allowance of the State Council, as directors of EII.
Professor Andrew Morris
Andrew is a Professor of Medicine, the Vice Principal of Data Science at the University of Edinburgh, and the inaugural Director of Health Data Research UK. His research interests span informatics and chronic diseases, including epidemiological and molecular studies on diabetes and its complications. He has published over 330 original papers on Nature, Lancet and other journals. He was Chief Scientist at the Scottish Government Health Directorate (2012-2017) and has served and chaired numerous national and international grant committees and governmental bodies. He was also the principal investigator of several programme grants, including the Wellcome Trust United Kingdom Case Control Collection for Type 2 Diabetes, Generation Scotland, a study of the genetic health in 50,000 Scots, the Wellcome Trust funded Scottish Health Informatics Programme (SHIP), and the Farr Institute in Scotland.
Professor Charles Swainson
Charles is a highly experienced medical director and renal specialist. As the Medical Director of EII he is a senior member of the management and operations team engaged in China healthcare projects. Charles graduated with an MBChB from Edinburgh in 1971, and was elected a Fellow of the Royal College of Physicians (FRCP) in 1985 and a Fellow of the Royal College of Surgeons of Edinburgh (FRCS Edinburgh) in 2003. Charles was the Medical Director of NHS Lothian Health Board and the Royal Infirmary of Edinburgh 1999-2010 where he also served as renal specialist 1986-2010. He is also a former advisor to the Scottish Government on eHealth.
Chairman Dr Tao David Jiang
Dr Jiang is the Chairman of EII, the team leader of the University of Edinburgh International Diabetes Centre (Shenzhen)and 2018 Sino-British Medical Education Award-winning Project, team member of the State Council Development Research Centre Project, and the executive director of the “Twelfth Five-Year Plan” National Science and Technology Support Project.
Dr Jiang has nearly 25 years of experience in hospital management consulting and investment management. He has led the wave of listing in Hong Kong, acquired and merged Chinese medical institutions, participated in the construction, transformation and management of more than 30 public and private hospitals, including China’s largest private third-class hospitals, prepared a new branch of Yunnan Cancer Hospital and restructured Chongqing Dadukou public hospital.
He led and participated in the restructuring of 42 hospitals controlled by Hongda Company of China Railway Group, Houkang Hospital in Xi’xian New District of Xi’an city, Shenzhen Fuwai Cardiovascular Hospital established by China Merchants Group, Wuhan Central Hospital of China Construction Group, Yunnan Traffic Hospital, and some other great medical projects.
In 2017, the University of Edinburgh and Shenzhen People’s Hospital were two members of the “Three Famous Project” award-winning team. Dr Jiang was also the core member of the medical team of “Peak Climbing Project” in Guangdong Province in 2018.
Dr Debbie Wake
B.Sc MBChB (Hons) MD ClinEdDip MRCPE
Debbie is a clinical NHS diabetes and endocrinology consultant and academic clinical senior lecturer. She is national clinical lead for NHS Scotland’s “MyDiabetesMyWay”, an award winning online data driven self-management platform for people with diabetes.
She has a national reputation for leadership/ expertise in informatics/ technology use in diabetes care, an area where she is extensively published. She is also clinical lead for the Kuwait-Scotland e-Health Innovation Network and leads on a number of Diabetes International Education Programmes from patient education to health care professional CPD and formal Postgraduate Programmes (e.g. Diploma/ MSc).
Debbie is a 2015-17 Diabetes UK Clinical Champion, a leadership role which has enabled her to achieve substantial diabetes care improvements both locally and around the world.
Dr. Angela Sun
MBChB PhD FRCPCH
Angela is a Consultant specialized in diabetes and endocrinology, and specially an expert at diabetes care for children and young adults.
She has vast experience from working in the UK’s NHS in Northern Scotland where she implemented many quality improvement measures to improve the treatment regimens for young patients.
As a hospital consultant she provides hands-on support in diabetes for paediatric wards, special baby units, accident and emergency, high risk births and stabilization of sick new born babies and mothers.
Dr Sun is also an experienced undergraduate and postgraduate teacher.